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ABSTRACT
DNA damage occurs via endogenous and exogen-
ous genotoxic agents and compromises a genome’s
integrity. Knowing where damage occurs within a
genome is crucial to understanding the repair mech-
anisms which protect this integrity. This paper
describes a new development based on microarray
technology which uses ultraviolet light induced DNA
damage as a paradigm to determine the position
and frequency of DNA damage and its subsequent
repair throughout the entire yeast genome.
INTRODUCTION
DNA damage occurs via endogenous and exogenous
genotoxic agents, generating base losses and modiﬁca-
tions, strand breaks, crosslinks, bulky chemical adducts
and other DNA alterations (1). If this damage remains
unrepaired, it will impact on DNA metabolism, result in
abnormal cellular activity and it can cause mutation or cell
death. To maintain genome integrity, cells have evolved a
variety of DNA repair mechanisms. One of these is nu-
cleotide excision repair (NER) which is well conserved
during evolution. In humans a NER deﬁciency predis-
poses affected individuals to a cancer-prone genetic
disorder, xeroderma pigmentosum (1).
NER removes a wide range of DNA lesions, and often
recognizes damages that distort the DNA helical structure
including ultraviolet light (UV) induced cyclobutane pyr-
imidine dimers (CPDs). More than 30 repair proteins have
been identiﬁed as having roles in NER on naked DNA
templates in vitro (1). In cells, DNA is tightly packaged as
chromatin and this poses a barrier to the operation of
these core proteins. The roles of these core proteins were
identiﬁed in part via studies with Saccharomyces
cerevisiae, and where NER has many homologous steps
to the mechanism in humans (1). How NER operates in
the context of chromatin remains elusive although some
inroads have been made in this area (2,3) often by employ-
ing methods to examine DNA damage and repair in
speciﬁc regions of a genome.
Technologies are available to examine DNA damage
and repair in selected genes (4) and certain damages can
be analyzed at nucleotide resolution in some of those
genes (5–7). However, none of these approaches are
designed to examine repair events throughout genomes
at a high resolution in order to identify the variations in
repair rate and reveal any correlation of this with changes
in chromatin structure. Such an approach would enable
one to examine the global inﬂuence of factors on repair:
for example, the accessibility of repair proteins to DNA
damage in chromatin and the chromatin modiﬁcation
factors that facilitate its repair.
To address this, there was a need to develop a new
approach to rapidly screen entire genomes for DNA
damage and to measure their repair. DNA microarrays
were developed decades ago for whole genome transcrip-
tion proﬁling. The combination of these and chromatin
immunoprecipitation, namely ChIP on chip, was an exten-
sion that enabled the identiﬁcation of the binding sites of
DNA-binding proteins and the covalent modiﬁcations to
nucleosomes on a genome-wide basis (8,9). Here, we
describe a genome wide approach that employs micro-
arrays to monitor UV-induced DNA damage (CPDs)
and its repair. Consequently, this enables us to identify
the UV-induced changes in chromatin and the chromatin
modiﬁcations that facilitate repair throughout an entire
genome.
MATERIALS AND METHODS
UV irradiation
Yeast cells were collected from an overnight culture in
Yeast Complete Medium (YPD) at a density of
2 10
7cells/ml. Pre-chilled PBS (137mM NaCl, 2.7mM
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resuspend the cells at a density of 2 10
7cells/ml. A
fraction of cells (200ml at 2 10
7cells/ml) was kept on
ice for the non-irradiated control sample (U). The
number of cells for each sample was always the same
and a non-irradiated control sample was always taken
for each strain in every experiment. A batch of 50ml of
cell suspension was placed in a Pyrex dish (=14cm)
and irradiated with 254nm UV light at a dose of
50J/m
2. The irradiated cells were kept in the dark in a
sterile ﬂask on ice. This irradiation step was repeated for
the rest of the cell suspension. The same volume of UV
treated cells taken for the U sample was collected to serve
as a 0 sample with no repair time. The remainder of the
UV-treated cells was collected by centrifugation and
re-suspended in a ﬂask of fresh YPD at 2 10
7cells/ml
and incubated at 30 C in the dark with vigorous shaking
for subsequent DNA repair analysis. At the 2-h repair
time point the same number of cells as for the U sample
was taken from the repairing culture.
DNA preparation
Cells collected at each point were resuspended in 5ml of
sorbitol solution [0.9M sorbitol, 0.1M Tris–HCl (pH 8.0),
0.1M EDTA]. 0.5ml of zymolyase 20T (10mg/ml in
sorbitol solution, ICN Biochemicals, Inc.) and 0.5ml of
0.28M b-mercaptoethanol was added to each sample
and mixed well by shaking. Cells were incubated at 30 C
for 1h in a shaking incubator. Spheroplasts were gently
centrifuged at 3000rpm for 5min and resuspended in 5ml
oflysis buffer [4M Urea, 200mMNaCl, 100mM Tris–HCl
(pH 8.0), 10mM CDTA, 0.5%(w/v) N-Lauroyl Sarcosine]/
PBS 1:1(v/v) solution. 0.5ml of DNase-free RNase A at
3mg/ml in TE buffer (Sigma-Aldrich, from bovine
pancreas, prepared as a 10mg/ml stock solution in
10mM sodium acetate buffer pH 5.2, and boiled for
15min at 100 C) was added to each sample. The samples
were vortexed and incubated at 37 C for 1h. Following
this 0.5ml of proteinase K (5mg/ml in TE buffer, freshly
made, Amresco) solution was added. The samples were
incubated at 37 C for 1h and then at 65 C for 1h with
occasional shaking. Phenol/chloroform (6ml) and chloro-
form (6ml) extractions were carried out prior to DNA pre-
cipitation with two volumes (12ml) of pre-chilled 100%
ethanol. DNA pellets were collected by centrifugation
and resuspended in 1ml of TE buffer. After being com-
pletely dissolved, the DNA samples were checked by
non-denaturing agarose gel electrophoresis and UV spec-
trophotometry (ND-1000, NanoDrop Technologies
Thermo scientiﬁc).
Fragmenting DNA by sonication
A bioruptor sonicator (Diagenode) was used to fragment
DNA with the water temperature in the sonication tank
kept at 4 C by a water circulation system. 1.5ml
Eppendorf tubes containing 300ml of DNA samples in
TE buffer were placed in a 1.5ml microtube unit. Power
was set to the ‘High’ position. Sonication was carried out
for 20s on and 40s off for 12 cycles. Fragmented DNA
was analyzed via agarose gel electrophoresis, and the
average fragment size was 400bp (data not shown and
http://www.diagenode.com/media/documents/downloads/
posters/PO-BR-A3-V2_22_06_10.pdf).
Immunoprecipitation (IP)
An amount of 50ml of Dynabeads (Mouse lgG, Invitrogen)
per sample were washed three times with 500ml PBS-BSA
(0.1%) per sample. The washed Dynabeads were resus-
pended in 100ml of PBS-BSA (0.1%) per sample with the
addition of the CPD antibody (Kamiya Biomedical
Company, Seattle Anti-Thymine Dimer Clone KTM53
50ml Dynabeads with 2–3ml of the provided CPD
antibody). The mixture was incubated at 30 C for 30min
at 1300rpm in an Eppendorf Thermomixer. Dynabeads
were collected and washed three times with 500mlo f
PBS–BSA (0.1%), 4 C, and resuspended in 50ml
PBS-BSA (0.1%)/sample. The suspension was separated
into 50-ml aliquots in fresh tubes and the supernatant
removed. An amount of 100ml of sonicated DNA
samples were added to each tube containing the
Dynabeads. An amount of 50mlo f1 0   PBS–BSA
(10mg/ml) was added to each sample, and the ﬁnal
volume was adjusted to 500ml with PBS. Samples were
incubated at 21 C for 2h at 1300rpm in an Eppendorf
Thermomixer followed by a wash with 500ml of freshly
prepared FA/SDS buffer (50mM HEPES KOH pH 7.5,
150mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1%
Deoxycholate Na, 0.1% SDS, 1mM PMSF). Further
washes were as follows: three times wash with 1ml of
FA/SDS+NaCl (adjust the NaCl concentration to
500mM); one wash with 500ml of Li solution (100mM
Tris–Cl pH 9.0, 500mM LiCl, 1% NP40, 1% deoxycholic
Na), one wash with 500ml of cold TE. DNA was eluted off
the Dynabeads with 100ml of Pronase (Promega) buffer
(25mM Tris pH 7.5, 5mM EDTA, 0.5% SDS) at 65 Ca t
900rpm for 20min. An amount of 6.25ml of Pronase
(20mg/ml, in H2O) was added to each sample and
incubated at 37 C for 1h, then at 65 C in a water bath,
overnight. The volume of the input samples (20ml), was
adjusted with TE buffer to 100ml followed by the
addition of 25mlo f5   Pronase buffer (125mM Tris
pH 7.5, 25mM EDTA, 2.5% SDS, 6.25ml of Pronase
at 20mg/ml). They were then incubated as the IP
samples. An amount of 1ml of the DNase-free RNase A
at 10mg/ml was added to the IP and input samples
followed by incubation at 37 C for 1h. DNA was
puriﬁed using the Qiagen PCR puriﬁcation kit and eluted
with 50ml elution buffer.
Repair of DNA damages prior to PCR ampliﬁcation
Immunoprecipitated DNA fragments obtained using the
CPD antibody will contain CPD damage which will block
DNA synthesis during the following PCR ampliﬁcation
step. Therefore, any damage has to be removed prior to
PCR. The PreCR DNA repair kit (New England Biolabs)
removes many DNA damages including CPDs. An
amount of 40ml of the IP samples and 1ml of input
samples diluted into 40ml with H2O, were subjected to
repair treatment using the PreCR DNA repair kit as per
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DNA end blunting and linker ligation
These were undertaken as described in the Agilent ChIP
on chip protocol for Yeast (http://www.chem.agilent.com/
Library/usermanuals/Public/ChIP-on-chip_Yeast_
9.2.pdf). In brief, 70ml of a mixture of T4 DNA Pol Buffer
(11ml, NEB buffer 2 included with the T4 polymerase).,
BSA (10mg/ml, 0.5ml), dNTP (10mM, 1.0ml), T4 DNA
polymerase (0.2ml from New England Biolabs (NEB).
Catalog # MO203S), H2O (57.8ml) were added to 50ml
of IP sample or input sample on ice. The samples were
mixed by pipetting and then incubated at 12 C in a water
bath for 20min. An amount of 11.5ml of NaAc (3M,
pH5.2) and 0.5ml of Glycogen (20mg/ml) were added
into each sample. After phenol/chloroform extraction,
the DNA was precipitated with absolute ethanol (–80 C
for 10min). DNA was pelleted by centrifugation and
washed once with cold 75% ethanol and resuspended in
25mlo fH 2O. An amount of 25ml of ligation mix (13mlo f
H2O, 5ml of DNA ligase buffer, 6.7ml of linker hybrid,
0.5ml of T4 DNA ligase) was added into each tube and
mixed for overnight ligation at 16 C in a water bath. An
amount of 6ml of NaAc (3M) was added to the ligation
mixture and the DNA was precipitated with absolute
ethanol at  80 C for 10min. DNA was pelleted by cen-
trifugation, washed once with cold 75% ethanol and re-
suspended in 25mlo fH 2O.
PCR ampliﬁcation
Two steps of PCR were carried out as described in the
Agilent ChIP on chip protocol with modiﬁcations. We
did this so as we could archive reasonable amounts of
each sample after the ﬁrst PCR and re-analyze samples
if required. For the ﬁrst PCR, 15ml of PCR mix (8mlo f
5  Buffer, 1.25ml of 10mM dNTP, 1.25mlo f4 0mM Oligo
102, 4.5mlo fH 2O) was added to each sample, and
incubated at 55 C for 4min in a PCR block. After the
ﬁrst 2-min incubation, the program was paused. An
amount of 10ml of Phusion DNA polymerase mixture
(1ml of Phusion Polymerase (New England Biolabs), 2ml
of 5  Buffer, 7mlo fH 2O) were added to each tube while
the tube was kept in the heating block. The program was
resumed and followed by 3min incubation at 72 C. After
a 1min 98 C denaturing step, 25 cycles of PCR were
applied as 10s at 98 C, 30s at 55 C and 1min at 72 C,
and the ﬁnal step was 5min at 72 C. Ten times dilution
was made to each PCR by adding 450mlo fH 2O. This can
be stored frozen for future use. A second PCR reaction
with 5ml of ﬁrst PCR dilution and 45ml of PCR mix (10ml
of 5 Buffer, 1.25ml of 10mM dNTP, 1.25mlo f4 0 mM
Oligo 102, 0.5ml of Phusion DNA Pol, 32mlo fH 2O)
was carried out using conditions of 98 C 1min, 25 cycles
of (98 C1 0 s ,5 5  C3 0 s ,7 2  C 1min), 72 C 5min. DNA
was precipitated with the addition of 25ml of 7.5M
Ammonium Acetate and 225ml of absolute ethanol at
 80 C for 10min. DNA was pelleted by centrifugation
and washed once with cold 75% ethanol and resuspended
in 20mlo fH 2O. The concentration of DNA was measured
with the NanoDrop spectrophotometer and all samples
normalized to100ng/ml with H2O.
Labeling
The BioPrime Total Genomic Labeling System
(Invitrogen) was used to label the DNA for ChIP on
chip. Generally the IP samples were labeled with Alexa
Fluor 5 (cy5) and the Input samples were labeled with
Alexa Fluor 3 (cy3). An amount of 17.6ml of ampliﬁed
DNA samples (100ng/ml) and 4.4ml of 5mM EDTA were
placed in a 0.5ml PCR tube. An amount of 25mlo f
2  Alexa Fluor 5 Reaction Mix or 2  Alexa Fluor 3
Reaction Mix were added into the tube and mixed. The
samples were incubated at 95 C in the dark for 5min and
immediately cooled on ice for 5min. While on ice, 3mlo f
Exo-Klenow Fragment (40units/ml and part of the
BioPrime Total Genomic Labeling Module, Invitrogen)
was added to each tube (total 50ml) and mixed. Samples
were incubated at 37 C for 2h in a heating block in the
dark. After the incubation, DNA was puriﬁed using an
Invitrogen column provided in the labeling system and
eluted in 55ml of elution buffer. Labeling efﬁciency was
determined using the MicroArray Measurement Module
on the Nanodrop ND-1000 Spectrophotometer. The
NanoDrop software facilitates the measurement of
DNA concentration and dye labeling effectiveness. The
NanoDrop ND-1000 Spectrophotometer measures the ab-
sorbance of the ﬂuorescent dye, allowing detection at dye
concentration as low as 0.2pmol/ml. (http://www
.nanodrop.com/Library/nd-1000-v3.7-users-manual-8
.5x11.pdf pg 30 for more details). An amount of 50mlo f
labeled IP sample and 50ml of labeled input samples were
combined, and precipitated by the addition of 12mlo f
NaAc (3M), 5ml of Polyacrylamide (2.5mg/ml) and
290ml of absolute ethanol at  80 C for 10min. DNA
was pelleted by centrifugation, washed once with cold
75% ethanol, and resuspended in 37.5mlo fH 2O.
Hybridization
To the 37.5ml of labeled samples were added 12.5mlo f
Human Cot-1 DNA (1.0mg/ml, Invitrogen), 12.5mlo f
Agilent Blocking Agent (10 ) and 62.5ml of Agilent
Hybridization Buffer (2x). 110ml of this hybridization mix-
ture was applied to each Agilent yeast microarray (4 44k)
http://www.genomics.agilent.com/CollectionSubpage
.aspx?PageType=Product&SubPageType=ProductData
&PageID=1476) for hybridization for 24h at 65 Ca s
described in the Agilent ChIP on chip protocol.
Washing and scanning
After hybridization the microarrays were washed and
scanned as described in the Agilent ChIP on chip protocol.
Feature extraction
The scanned image was analyzed by Agilent Feature
extraction software. Red and green background subtracted
signals were used for data analysis.
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Detecting CPDs throughout the entire yeast genome
Yeast cells were irradiated with UV and then sampled
either immediately or allowed a 2h repair period. DNA
puriﬁed from an unirradiated control (U), immediately
after UV (0) and after UV with the 2-h repair period
was sonicated to generate short fragments ranging from
200 to 800bp and averaging 400bp (input samples).
Immunoprecipitation with the CPD antibody was
carried out for unirradiated and UV irradiated samples
(IP samples). We consistently detected over a 50-fold en-
richment of DNA in the UV exposed samples compared
with the unirradiated samples. We processed the IP and
the input samples for microarray analysis employing the
Agilent 4 44K yeast microarrays by labeling the IP
sample with cy5 and the input sample with cy3. The
ratio of the signals between the IP and the input samples
for each probe on the microarray indicates the relative
level of CPDs detected at the region the probe locates.
Figure 1 shows a snapshot of CPD induction in part of
chromosome 4 following a UV dose of 50J/m
2. The data
are the average of two independent experiments. The
black line indicates the relative CPD level detected with
the CPD antibody using the log2 ratio of the IP and the
input sample signals, with the peaks representing high
levels and the troughs low levels of CPDs. Error bars
shown on the black line are 1 SD from the mean from
the two individual experiments. It is evident that the
induction of CPDs is heterogeneous along the genome.
Theoretical CPD distribution throughout the entire
yeast genome
UV light, speciﬁcally at or near to 254nm, is close to the
maximum absorption wavelength of DNA. This UV radi-
ation can generate many lesions, mainly at adjacent pyr-
imidine sites. Two adjacent pyrimidines in the same
polynucleotide chain can absorb UV energy to form a
four-membered ring structure, a CPD, resulting from sat-
uration of the C=C double bonds. CPDs form solely at
adjacent pyrimidine sites, and their position is determined
by the DNA sequence. The yield is inﬂuenced by the
nucleotide composition of DNA and the quantitative
ratio of CPD formation after UV irradiation at TT, TC,
CT, CC sites is 68:16:13:3 as measured with plasmid DNA
(10) or human cells (11). Based on this ratio, we mathem-
atically modeled the theoretical CPD distribution for the
whole yeast genome from its sequence by taking account
of the mean sheared average DNA fragment size of
400bp.
A Perl script was written to generate a predicted binding
level for each probe on the microarray based on the
frequency of dipyrimidine sequences in the genomic
region surrounding the  60-nt region complementary to
the probe sequence. At each complementary probe
location the genomic region able to bind that probe was
analyzed. This was calculated as the length of the mean
sheared DNA fragment size up and downstream of the
end and start of the complementary probe region, giving
a sequence twice the length of the mean sheared DNA
fragment size minus the probe size (Figure 2).
For each probe sequence region, a value was calculated
for all dipyrimidines which were summed to assign a value
to the probe, using the following Formula 1.
Figure 1. The CPD distribution in a part of Chromosome 4. Black: CPD level detected by the CPD antibody. Error bars shown on the black line are
1 SD from the mean from the two individual experiments. Red: theoretical CPD distribution. For the genome representations here and in the
supplementary ﬁgures: yellow boxes show ORF positions (arrows indicate direction of transcription), green boxes are ARSs and blue boxes are
centromeres and telomeres. Grey dots show probe positions.
Figure 2. An outline showing the detectable genomic region for a
probe (not to scale). All detectable fragments are in blue.
Formula 1. Calculation of CPD probe values. s=dipyrimidine site,
n=numberof dipyrimidine sites, f=meanfragment length, d=distance
of dipyrimidine site from probe, P=probability of a CPD occurring at
the dipyrimidine site (TT/AA=0.68, TC/GA=0.16, CT/AG=0.13,
CC/GG=0.03).
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sequence (red line) against the detected CPD values
(black line) in part of the chromosome 4 (Figure 1) and
for the entire genome (Supplementary Figure S1) show a
remarkably good relationship. The Spearman rank correl-
ation co-efﬁcient (a non-parametric test) is 0.83 for the
probes in Figure 1 and 0.77 for the entire genome, both
with P<0.001. Hence there is statistically signiﬁcant
relationship between the two sets of values.
Repair of CPDs in wild type and rad4 cells
The comparison of the CPD levels immediately after UV
versus 2h repair in medium after UV should reﬂect the
repair extent. We conﬁrmed that these changes in signals
actually reﬂect repair in two ways. First, whilst NER
operates to remove CPDs from the nuclear genome,
CPDs in mitochondrial DNA persist because NER does
not operate in this organelle (12,13). The Agilent
S. cerevisiae microarray includes hundreds of probes for
detecting the mitochondrial genome. Therefore, the per-
sistence of CPDs in mitochondrial DNA (Figure 3) serves
as one quality control for interpreting the changes in the
CPD levels seen with the nuclear probes. An example of
the relative 2h repair rate for part of chromosome 4 in
repair competent cells is shown in Figure 4 (black line).
Here the data are the average of two independent experi-
ments. The peaks indicate fast repair and the troughs
indicate slow repair. Repair is heterogeneous along
the genome with a varied repair rate from region to
region. Data for the whole genome are presented in
Supplementary Figure S2.
To further verify that the change in CPDs detected at
2-h repair after UV is due to repair, CPDs were measured
in a NER-deﬁcient rad4 mutant. This strain has a deletion
of the yeast gene homologous to that which is defective in
human xeroderma pigmentosum sufferers belonging to
complementation group C, and who are cancer-prone
(1). In S. cerevisiae the rad4 mutant is defective in both
global and transcription-coupled NER (1,14). CPD repair
was not detected, as shown by the red line in Figure 4
(the whole genome data are supplied in Supplementary
Figure S2). These rad4 data are the average of three inde-
pendent experiments. Thus the changes in this ratio in
the NER proﬁcient cells are unequivocally due to NER.
Consequently, this microarray approach can measure
CPD induction and repair throughout the genome.
DISCUSSION
This combination of immunoprecipitation and microarray
technology for examining the presence of DNA damage
enables researchers to analyze repair events throughout
an entire genome. Analyses of genome-wide DNA repair
can be undertaken, alongside examination of the DNA
damage-induced changes in chromatin that facilitate
repair. For example, one can examine UV-induced
changes in histone acetylations, other covalent histone
modiﬁcations, the recruitment of speciﬁc enzymes such as
histone acetyltranferases and histone deacetylases, the
changes in nucleosome positions and the chromatin
remodeling factors responsible for this. These events
can be examined alongside the sequential recruitment of
DNA repair enzymes. Such experiments are crucial to
identify where in the genome the requirements differ for
the chromatin modiﬁcation enabling efﬁcient NER (2).
The approach should be applicable to examining other
DNA damages provided either the antibodies or the
tagged DNA damage recognition enzymes are available
to immunoprecipitate those speciﬁc DNA damages, and
provided that any of those damages that block PCR can
be repaired to enable PCR. Those damages repairable by
the PreCR kit can be seen on the following web site: http://
www.neb.com/nebecomm/products/productM0309.asp.
For damages not repairable by this kit (e.g. 8-oxo-7,
8-dihydro-20adenosine), an alternative means of repair
could be sought. The method should be applicable to
studies with human cells via the available higher resolution
human microarrays. Studies with human cells would
employ 5–20J/m
2 at 260nm, as these cells are more UV
sensitive than is yeast; experiments are underway to
optimize this approach with such cells. DNA samples
prepared for this microarray-based approach can be
readily processed for high throughput sequencing analysis
if this is preferred, or if microarrays are unavailable for the
organism of interest.
Finally, the technique has implications for monitoring
the targets of existing and new anti-cancer chemo-
therapeutics that act through damaging DNA, or for
genotoxicity testing. It will enable an estimation of the
target sequences for DNA damage and whether these
interactions persist in cells. A British Initial Patent appli-
cation covering the technology was ﬁled at the UK patent
ofﬁce on 28 June 2007, it entered the international PCT
phase in 06/08 patent No. 0712584.2
Figure 3. Scatter plot of CPD levels before repair (CPD 0h) versus at
2h repair (CPD 2h). Red symbols: mitochondrial DNA (probes for all
coding region in mitochondrial DNA where the GC content is closer to
than in nuclear DNA); Grey symbols: nuclear DNA. Each data point is
for a speciﬁc genomic probe.
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